Blauvelt A, Korman N, Mollon P, Zhao Y, Milutinovic M, You R, Sherif B, Williams N, Fox T, Augustin M. Secukinumab treatment provides faster and more effective relief from patient-reported quality of life impact than ustekinumab in subjects with moderate to severe plaque psoriasis. Poster presented at the 4th Annual Maui Derm NP+PA Summer Meeting; June 2016. Colorado Springs, CO. Previously presented at the 24th European Academy of Dermatology and Venereology Congress.


Abstract not available at this time.

Share on: